Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sasi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Laboratory|August 17, 2022
Programmed for Automatic Bone Disorder Clustering Based on Cumulative Calcium Prediction for Feature ExtractionS Ramkumar, M Rajeev Kumar, G Sasi
Malaria Journal|June 3, 2014
Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapyBetty A Maganda, Omary M S Minzi, Appolinary A R Kamuhabwa, et al.
BMC Infectious Diseases|June 24, 2024
Hypertension and immune activation in antiretroviral therapy naïve people living with human immunodeficiency virusTosi M Mwakyandile, Grace A Shayo, Philip G Sasi, et al.
BMC Cardiovascular Disorders|June 20, 2023
Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV- infected adults initiating antiretroviral therapy in Urban TanzaniaTosi M Mwakyandile, Grace A Shayo, Philip G Sasi, et al.
Southern African Journal of HIV Medicine|February 19, 2025
Kidney disease among adults on tenofovir-based second-line antiretroviral therapy in Dar es Salaam, TanzaniaSabina F Mugusi, Grace A Shayo, Philip G Sasi, et al.
Plos One|August 29, 2025
Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trialTosi M Mwakyandile, Grace A Shayo, Philip G Sasi, et al.
Antiviral Therapy|February 2, 2012
Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, TanzaniaSabina F Mugusi, Eliford Ngaimisi, Mohamed Y Janabi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Laboratory|August 17, 2022
Programmed for Automatic Bone Disorder Clustering Based on Cumulative Calcium Prediction for Feature ExtractionS Ramkumar, M Rajeev Kumar, G Sasi
Malaria Journal|June 3, 2014
Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapyBetty A Maganda, Omary M S Minzi, Appolinary A R Kamuhabwa, et al.
BMC Infectious Diseases|June 24, 2024
Hypertension and immune activation in antiretroviral therapy naïve people living with human immunodeficiency virusTosi M Mwakyandile, Grace A Shayo, Philip G Sasi, et al.
BMC Cardiovascular Disorders|June 20, 2023
Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV- infected adults initiating antiretroviral therapy in Urban TanzaniaTosi M Mwakyandile, Grace A Shayo, Philip G Sasi, et al.
Southern African Journal of HIV Medicine|February 19, 2025
Kidney disease among adults on tenofovir-based second-line antiretroviral therapy in Dar es Salaam, TanzaniaSabina F Mugusi, Grace A Shayo, Philip G Sasi, et al.
Plos One|August 29, 2025
Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trialTosi M Mwakyandile, Grace A Shayo, Philip G Sasi, et al.
Antiviral Therapy|February 2, 2012
Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, TanzaniaSabina F Mugusi, Eliford Ngaimisi, Mohamed Y Janabi, et al.
Pageof 1